Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: Implications for therapy with a monoclonal antibody directed to the IL-2/15Rβ receptor

Journal of Immunology

Volumn 163, Issue 7, 1999, Pages 4064-4072

  Azimi, Nazli ^a   Jacobson, Steven ^b   Leist, Thomas ^b   Waldmann, Thomas A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOCKING ANTIBODY; CYTOKINE; GROWTH FACTOR; INTERLEUKIN 15 RECEPTOR; INTERLEUKIN 2 RECEPTOR; MESSENGER RNA; MONOCLONAL ANTIBODY;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN TISSUE; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE;

ANTIBODIES, MONOCLONAL; ASTROCYTES; CELL LINE; CELLS, CULTURED; GENE PRODUCTS, TAX; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; INTERLEUKIN-15; INTERLEUKIN-2; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; PARAPARESIS, TROPICAL SPASTIC; RECEPTORS, INTERLEUKIN-15; RECEPTORS, INTERLEUKIN-2; RNA, MESSENGER; T-LYMPHOCYTES; UP-REGULATION;

EID: 0033214401     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Poiesz, B. J., F. W. Ruscetti, A. F. Gazdar, P. A. Bunn, J. D. Minna, and R. C. Gallo. 1980. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA 77:7415.
2. Gessain, A., F. Barin, J. C. Vernant, O. Gout, L. Maurs, A. Calender, and G. de The. 1985. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 24:407.
3. Osame, M., K. Usuku, S. Izumo, N. Ijichi, H. Amitani, A. Igata, M. Matsumoto, and M. Tara. 1986. HTLV-1 associated myelopathy, a new clinical entity. Lancet 1:1031.
4. Mochizuki, M, T. Watanabe, K. Yamaguchi, K. Takatsuki, K. Yoshimura, M. Shirao, S. Nakashima, S. Mori, S. Araki, and N. Miyata. 1992. HTLV-1 uveitis: a distinct clinical entity caused by HTLV-1. Jpn. J. Cancer Res. (GANN) 5:29.
5. Morgan, O. S., P. Rodgers-Johnson, C. Mora, and G. Char. 1989. HTLV-1 and polymyositis in Jamaica. Lancet 2:1184.
6. Sato, K., I. Maruyama, Y. Maruyama, I. Kitajima, Y. Nakajima, M. Higaki, K. Yamamoto, N. Miyasaka, M. Osame, and K. Nishioka. 1991. Arthritis in patients infected with human T lymphotropic virus type I: clinical and immunopathologic features. Arthritis Rheum. 34:714.
7. Sugimoto, M., H. Nakashima, S. Watanabe, E. Uyama, F. Tanaka, M. Ando, S. Araki, and S. Kawasaki. 1987. T-lymphocyte alveolitis in HTLV-1-associated myelopathy. Lancet 2:1220.
8. Higuchi, I., E. S. Montemayor, S. Izumo, M. Inose, and M. Osame. 1993. Immunohistochemical characteristics of polymyositis in patients with HTLV-1-associated myelopathy and HTLV-1 carriers. Muscle Nerve 16:472.
9. Inoue, J., M. Seiki, and M. Yoshida. 1986. The second pX product p27 chi-III of HTLV-I is required for gag gene expression. FEBS Lett. 209:187.
10. Siekevitz, M. F., M. B. Feinberg, N. Holbrook, F. Wong-Staal, and W. C. Greene. 1987. Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by trans-activator (tax) gene product of human T cell leukemia virus type I. Proc. Natl. Acad. Sci. USA 84:5389.
11. Cross, S. L., M. B. Feinberg, J. B. Wolf, N. J. Holbrook, F. Wong-Staal, and W. J. Leonard. 1987. Regulation of the human interleukin 2 receptor α chain promoter: activation of a nonfunctional promoter by the transactivator gene of HTLV-I. Cell 49:47.
12. Jacobson, S. 1995. Human T lymphotropic virus, type-I myelopathy: an immunopathologically mediated chronic progressive disease of the central nervous system. Curr. Opin. Neurol. 8:179.
13. Jacobson, S., D. E. McFarlin, S. Robinson, R. Voskuhl, R. Martin, A. Brewah, A. J. Newell, and S. Koenig. 1992. HTLV-I-speciftc cytotoxic T lymphocytes in the cerebrospinal fluid of patients with HTLV-I-associated neurological disease. Ann. Neurol. 32:651.
14. + cytotoxic T lymphocytes specific for HTLV-1 pX in patients with HTLV-1-associated neurological disease. Nature 348:245.
15. + lymphocytes in the spinal cord from patients with HTLV-I-associated myelopathy. J. Neuroimmunol. 53:23.
16. Ijichi, S., N. Eiraku, M. Osame, S. Izumo, R. Kubota, I. Maruyama, M. Matsumoto, T. Niimura, and S. Sonada. 1989. Activated T lymphocytes in cerebrospinal fluid of patients with HTLV-1-associated myelopathy (HAM/TSP). J. Neuroimmunol. 25:251.
17. Jacobson, S., V. Zaninovic, C. Mora, P. Rodgers-Johnson, W. A. Sheremata, C. J. Gibbs, D. C. Gajusek, and H. E. McFarland. 1988. Immunological findings in neurological diseases: activated lymphocytes in tropical spastic paraparesis. Ann. Neurol. 23:196.
18. Itoyama, Y., S. Minato, J. Kira, I. Goto, H. Sato, K. Ikochi, and N. Yamamoto. 1988. Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV-1 associated myelopathy. Neurology 38:816.
19. Tendler, C. L., S. J. Greenberg, W. A. Blattner, A. Manns, E. Murphy, T. Fleisher, B. Hanchard, O. Morgan, J. D. Burton, D. L. Nelson, and T. A. Waldmann. 1990. Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy. Proc. Natl. Acad. Sci. USA 87:5218.
20. Azimi, N., K. Brown, R. N. Bamford, Y. Tagaya, U. Sibenlist, and T. A. Waldmann. 1998. Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-κB site. Proc. Natl. Acad. Sci. USA 95:2452.
21. Grant, A. J., E. Roessler, G. Ju, M. Tsudo, K. Sugamara, and T. A. Waldmann. 1992. The interleukin 2 receptor (IL-2R): the IL-2R α subunit alters the function of the IL-2R β subunit to enhance IL-2 binding and signaling by mechanisms that do not require binding of IL-2 to IL-2R α subunit. Proc. Natl. Acad. Sci. USA 89:2156.
22. Giri, J. G., M. Ahdieh, J. Eisenman, K. Shanebeck, S. Kumaki, A. Namen, L. S. Park, D. Cosman, and D. Anderson. 1994. Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 13:2822.
23. Bamford, R. N., A. J. Grant, J. D. Burton, C. Peters, G. Kurys, C. K. Goldman, J. Brennan, E. Roessler, and T. A. Waldmann. 1994. The interleukin (IL) 2 receptor β chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc. Natl. Acad. Sci. USA 91:4940.
24. Uchiyama, T., S. Border, and T. A. Waldmann. 1981. A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells: production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. J. Immunol. 126:1393.
25. Tsudo, M., F. Kitamura, and M. Miyasaka. 1989. Characterization of the interleukin 2 receptor β chain using three distinct monoclonal antibodies. Proc. Natl. Acad. Sci. USA 86:1982.
26. Bamford, R. N., A. P. Battiata, J. D. Burton, H. Sharma, and T. A. Waldmann. 1996. Interleukin (IL) 15/IL-T production by the adult T-cell leukemia cell line HuT-102 is associated with a human T-cell lymphotropic virus type I R region/ IL-15 fusion message that lacks many upstream AUGs that normally attenuate IL-15 mRNA translation. Proc. Natl. Acad. Sci. USA 93:2897.
27. Tendler, C. L., S. J. Greenberg, J. D. Burton, D. Danielpour, S. J. Kim, W. A. Blattner, A. Manns, and T. A. Waldmann. 1991. Cytokine induction in HTLV-1 associated myelopathy and adult T-cell leukemia: alternate molecular mechanisms underlying retroviral pathogenesis. J. Cell. Biochem. 46:302.
28. Lehky, T. J., C. H. Fox, S. Koenig, M. C. Levin, N. Flerlage, S. Izumo, E. Sato, C. S. Raine, M. Osame, and S. Jacobson. 1995. Detection of human T lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I associated myelopathy/tropical spastic paraparesis by in situ hybridization. Ann. Neurol. 37:246.
29. Brady, J. N. 1996. Biology of HTLV-I: host cell interactions. In Human T-Cell Lymphotropic Virus Type I. P. Hollsberg and D. A. Hafler, eds. John Wiley & Sons Ltd, London, p. 79.
30. Ali, A., S. Patterson, K. Cruickshank, P. Rudge, A. G. Dalgleish, and S. C. Knight. 1993. Dendritic cell infected in vitro with human T cell leukemia/ lymphoma virus type-I (HTLV-I): enhanced lymphocytic proliferation and tropical spastic paraparesis. Clin. Exp. Immunol. 94:32.
31. Macatonia, S., J. K. Cruickshank, P. Rudge, and S. C. Knight. 1992. Dendritic cells from pateints with tropical spastic paraparesis are infected with HTLV-I and stimulate autologous lymphocyte proliferation. AIDS Res. Hum. Retroviruses 8:1699.
32. Ho, D. D., T. R. Rota, and M. S. Hirsch. 1984. Infection of human endothelial cells by human T-lymphotropic virus type I. Proc. Natl. Acad. Sci USA 81:7588.
33. Yoshikura, H., J. Nishida, M. Yoshida, Y. Kitamura, F. Takaku, and S. Ikeda. 1984. Isolation of HTLV-I derived from Japanese adult T cell leukemia patients in human diploid fibroblast strain IMR90 and the biological characters of the infected cells. Int. J. Cancer 33:745.
34. Lee, Y. B., J-I. Satoh, D. G. Walker, and U. K. Seung. 1996. Interleukin 15 gene expression in human astrocytes and microglia in culture. NeuroReport 7:1062.
35. Reinecker, H.-C., R. MacDermott, S. Mirau, A. Dignass, and D. Podolsky. 1996. Intestinal epithelial cells both express and respond to interleukin 15. Gastroenterology 111:1706.
36. Doherty, T. M., A. S. Seder, and A. Sher. 1996. Induction and regulation of IL-15 expression in murine macrophages. J. Immunol. 156:735.
37. Ogasawara, K., S. Hida, N. Azimi, Y. Tagaya, T. Sato, T. Yokochi-fukuda, T. A. Waldmann, T. Taniguchi, and S. Taki. 1998. Requirement for IRF-I in the microenvironmenl supporting development of natural killer cells. Nature 391: 700.
38. Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation and function of NF-kB. Annu. Rev. Cell Biol. 10:405.
39. Tanaka, N., and T. Taniguchi. 1992. Cytokine gene regulation: regulatory cis-elements and DNA binding factors involved in the interferon system. Adv. Immunol. 52:263.
40. Hollsberg, P., and D. A. Hafler. 1993. Pathogenesis of diseases induced by human lymphotropic virus type I infection. N. Engl. J. Med. 328:1173.
41. Nakamura, S., M. Nagano, M. Yoshiola, S. Shimazaki, and J. Onodera. 1993. Detection of tumor necrosis factor-α-positive cells in cerebrospinal fluid of patients with HTLV-I-associated myelopathy. J. Neuroimmunol. 42:127.
42. Kuroda, Y., and M. Matsui. 1993. Cerebrospinal fluid interferon-gamma is increased in HTLV-1-associated myelopathy. J. Neuroimmunol. 42:223.
43. Damjanovich, S., L. Bene, J. Matko, A. Alileche, C. K. Goldman, S. Sharrow, and T. A. Waldmann. 1997. Preassembly of interleukine 2 (IL-2) receptor subunits on resting Kit 225 K6 T cells and their modulation by IL-2, IL-7, and IL-15: a fluoroescence resonance energy transfer study. Proc. Natl. Acad. Sci. USA 94:13134.
44. Hanisch, U. K., and R. Quirion. 1996. Interleukin-2 as a neuroregulatory cytokine. Brain Res. Rev. 21:246.
45. Hanisch, U. K., S. A. Lyons, M. Prinz, C. Nolte, J. R. Weber, H. Kettenmann, and F. Kirchoff. 1997. Mouse brain microglia express interleukin-15 and its multimeric receptor complex functionally coupled to Janus kinase activity. J. Biol. Chem. 272:28853.
46. Inagaki-Ohara, K., H. Nishimura, A. Mitani, and Y. Yoshikai. 1997. Interleukin 15 preferentially promotes the growth of intestinal intraepithelial lymphocytes bearing γδ T cell receptor in mice. Eur. J. Immunol. 27:2885.
47. Jullien, D., P. A. Sieling, K. Uyemura, N. D. Mar, T. H. Rea, and R. L. Modlin. 1997. IL-15, an immunomodulator of T cell responses in intracellular infection. J. Immunol. 158:800.
48. Leclercq, G., V. Debaker, M. D. Smedt, and J. Plum. 1996. Differential effects of interleukin-15 and interleukin-2 on differentiation of bipotentail T/natural killer progenitor cells. J. Exp. Med. 184:325.
49. Wilkinson, P. C., and F. Y. Liew. 1995. Chemoattraction of human blood T lymphocytes by interleukin 15. J. Exp. Med. 181:1255.
50. + T cells in vivo by IL-15. Immunity 8:591.
51. Puzanov, I. J., N. S. Williams, J. Schatzle, P. V. Sivakumar, M. Bennett, and V. Kumar. 1997. Ontogeny of NK cells and the bone marrow microenvironment: where does IL-15 fit in? Res. Immunol. 148:198.
52. Atedzoe, B. N., A. Ahmad, and J. Menezes. 1997. Enhancement of natural killer cell cytotoxicity by the human herpesvirus-7 via IL-15 induction. J. Immunol. 159:4966.
53. Flamand, L., I. Stefanescu, and J. Menezes. 1996. Human Herpesvirus-6 enhances natural killer cell cytotoxicity via IL-15. J. Clin. Invest. 97:1373.
54. Carson, W., M. Ross, R. Baiocchi, M. J. Marien, K. H. Boiani, H. Grabstein, and M. A. Caligiuri. 1995. Endogenoues production of interferon γ by natural killer cells in vitro. J. Clin. Invest. 96:2578.
55. Lehky, T. L., M. C. Levin, R. Kubota, R. Bamford, A. N. Flerage, S. Soldan, T. P. Leist, A. Xavier, J. D. White, M. Brown, et al. 1998. Reduction in HTLV-1 proviral load and spontaneous lymphoproliferation in HAM/TSP patients treated with humanized Anti-Tac (anti-IL-2Rα). Ann. Neurol. 44:942.